Turn Therapeutics Inc(TTRX)
$10.57+0.65 (+6.55%)
TTRX
Turn Therapeutics Inc financials statements
$10.57
At close:+0.65 (+6.55%)
Want to see TTRX full AI Analyst Report?
Turn Therapeutics Inc (TTRX) Ratios
30 Followers
Turn Therapeutics Inc Ratios
TTRX's free cash flow for Q3 2026 was $-1.55M. For the 2026 fiscal year, TTRX's free cash flow was increased by $0.00 and operating cash flow was $-1.55M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.87 | 1.55 | 2.45 | ― |
| Quick Ratio | 0.87 | 1.55 | 2.45 | ― |
| Cash Ratio | 0.85 | 1.23 | 2.41 | ― |
| Solvency Ratio | -0.42 | -0.77 | -1.17 | ― |
| Operating Cash Flow Ratio | -0.43 | -1.92 | -2.81 | ― |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | ― |
| Net Current Asset Value | $ -2.28M | $ -1.13M | $ -725.98K | ― |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.01 | 0.06 | 0.01 | ― |
| Debt-to-Equity Ratio | 0.02 | -0.68 | 0.29 | ― |
| Debt-to-Capital Ratio | 0.02 | -2.15 | 0.23 | ― |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | ― |
| Financial Leverage Ratio | 2.60 | -11.55 | 23.48 | ― |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | ― |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | ― |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | ― |
| Interest Debt Per Share | 0.01 | 0.01 | 0.00 | ― |
| Net Debt to EBITDA | 1.59 | 0.44 | 0.51 | ― |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | ― |
| EBIT Margin | 0.00% | 0.00% | 0.00% | ― |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | ― |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | ― |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | ― |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | ― |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | ― |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | ― |
| EBT Per EBIT | 54.52% | 98.40% | 99.31% | ― |
| Return on Assets (ROA) | -26.26% | -86.31% | -113.84% | ― |
| Return on Equity (ROE) | -68.15% | 996.67% | -2672.64% | ― |
| Return on Capital Employed (ROCE) | -95.13% | -134.02% | -151.48% | ― |
| Return on Invested Capital (ROIC) | -94.42% | -130.07% | -149.02% | ― |
| Return on Tangible Assets | -28.42% | -144.13% | -184.32% | ― |
| Earnings Yield | -5.90% | -1.88% | 0.00% | ― |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | ― |
| Payables Turnover | 0.00 | 0.00 | 0.00 | ― |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | ― |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | ― |
| Asset Turnover | 0.00 | 0.00 | 0.00 | ― |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | ― |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | ― |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | ― |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | ― |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | ― |
| Operating Cycle | 0.00 | 0.00 | 0.00 | ― |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.19 | -0.10 | 0.00 | ― |
| Free Cash Flow Per Share | -0.20 | -0.11 | 0.00 | ― |
| Dividend Paid and CapEx Coverage Ratio | -16.75 | -13.68 | -31.09 | ― |
| Capital Expenditure Coverage Ratio | -16.75 | -13.68 | -31.09 | ― |
| Operating Cash Flow Coverage Ratio | -31.89 | -11.25 | -54.77 | ― |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | ― |
| Free Cash Flow Yield | -5.02% | -1.55% | 0.00% | ― |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -17.13 | -53.85 | 0.00 | ― |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | ― |
| Price-to-Book (P/B) Ratio | 11.55 | -529.55 | 0.00 | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -19.94 | -64.32 | 0.00 | ― |
| Price-to-Operating Cash Flow Ratio | -21.13 | -69.02 | 0.00 | ― |
| Price-to-Earnings Growth (PEG) Ratio | -0.22 | 2.29 | 0.00 | ― |
| Enterprise Value Multiple | -15.65 | -54.16 | 0.51 | ― |
| Enterprise Value | 49.16M | 93.21M | -1.16M | ― |
| EV to EBITDA | -15.65 | -54.16 | 0.51 | ― |
| EV to Sales | 0.00 | 0.00 | 0.00 | ― |
| EV to Free Cash Flow | -18.10 | -63.81 | 0.81 | ― |
| EV to Operating Cash Flow | -19.18 | -68.47 | 0.84 | ― |
| Tangible Book Value Per Share | 0.27 | -0.07 | 0.00 | ― |
| Shareholders’ Equity Per Share | 0.34 | -0.01 | 0.00 | ― |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | ― |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | ― |
| Net Income Per Share | -0.23 | -0.13 | 0.00 | ― |
| Tax Burden | 1.00 | 1.00 | 1.00 | ― |
| Interest Burden | 1.00 | 1.00 | 0.99 | ― |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | ― |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | ― |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | ― |
| Income Quality | 0.80 | 0.77 | 0.60 | ― |
Currency in USD
